Neurotrack
Redwood City, US · Founded 2012 · Delaware corporation · 47 employees on LinkedIn · 3 known investors
Neurotrack provides remote cognitive assessment tools for clinicians to detect early cognitive decline through eye-tracking technology, enabling earlier intervention for patients at risk of Alzheimer's and cognitive conditions. The company serves health systems, health plans, and clinical providers seeking to screen for mild cognitive impairment before symptom progression.
Founders & leadership
Neurotrack was founded in 2012 by Elli Kaplan, Dr. Stuart Zola, Dr. Elizabeth Buffalo, and Cecelia Manzanares.
Investors · 3
Reported raises · per SEC filings
Form D private placements$31.9M disclosed across 3 rounds · 2014–2019
▶$21.1MraisedJun 2019 · 7 investors · Other Health CareRule 506(b)
- Elli KaplanExecutive Officer, Director
- Phil WickhamDirector
- Samir KaulDirector
- Cheryl ScottDirector
- Offering amount
- $21.1M
- Amount sold
- $21.1M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.9MraisedMay 2017 · 11 investors · Other Health CareRule 506(b)
- Elli KaplanExecutive Officer, Director, Promoter
- Elli KaplanDirector
- Elli KaplanDirector
- Offering amount
- $10.9M
- Amount sold
- $9.9M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1MraisedDec 2014 · 1 investors · Other Health CareRule 506(b)
- Elli KaplanExecutive Officer, Director, Promoter
- Michael JohnsDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Neurotrack for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $298.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $225.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Neurotrack do?
- Neurotrack provides remote cognitive assessment tools for clinicians to detect early cognitive decline through eye-tracking technology, enabling earlier intervention for patients at risk of Alzheimer's and cognitive conditions. The company serves health systems, health plans, and clinical providers seeking to screen for mild cognitive impairment before symptom progression.
- Who founded Neurotrack?
- Neurotrack was founded by Elli Kaplan, Dr. Stuart Zola, Dr. Elizabeth Buffalo, Cecelia Manzanares in 2012.
- Who are Neurotrack's investors?
- Neurotrack's investors include Rethink Impact, Sozo Ventures, Venture Capital Investment Management.
- How much funding has Neurotrack raised?
- Neurotrack has disclosed $31.9M raised across 3 rounds.
- Where is Neurotrack headquartered?
- Neurotrack is headquartered in Redwood City, US.